title: Safety of endotracheal rh DNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children.
authors.forename: B
authors.initials: B
authors.lastname: Boeuf
authors.forename: F
authors.initials: F
authors.lastname: Prouix
authors.forename: S
authors.initials: S
authors.lastname: Morneau
authors.forename: D
authors.initials: D
authors.lastname: Marton
authors.forename: J
authors.initials: J
authors.lastname: Lacroix
mesh_terms: D002648:Child; D002675:Child, Preschool; D003850:Deoxyribonuclease I / Q000008:administration & dosage* / Q000009:adverse effects; D005100:Expectorants / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005334:Fever / Q000209:etiology; D006801:Humans; D000860:Hypoxia / Q000209:etiology; D007223:Infant; D007322:Instillation, Drug; D007442:Intubation, Intratracheal; D008297:Male; D001261:Pulmonary Atelectasis / Q000188:drug therapy* / Q000628:therapy; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D012121:Respiration, Artificial; D016896:Treatment Outcome
chemical_list: D005100:Expectorants; D011994:Recombinant Proteins; C085693:DNASE1 protein, human; D003850:Deoxyribonuclease I